상세 보기
Three-week schedule of irinotecan plus cisplatin in patients with previously untreated extensive-stage small-cell lung cancer
- Hong, Y. S.;
- Lee, H. R.;
- Park, S.;
- Lee, S. C.;
- Hwang, I. G.;
- ... Lee, J.;
- ... Ahn, J. S.;
- 외 4명
WEB OF SCIENCE
16SCOPUS
18초록
Irinotecan and cisplatin demonstrated promising outcomes in extensive-stage small-cell lung cancer. According to the dosage and schedule of irinotecan, efficacy and toxicity profiles showed subtle differences. This study was designed to evaluate efficacy and toxicity of 3-week schedule of irinotecan/cisplatin in patients with previously untreated extensive-stage small-cell lung cancer. The primary objective was to evaluate response rate and secondary objectives were overall survival and progression-free survival. Patients with previously untreated extensive-stage small-cell lung cancer were enrolled. Irinotecan 65 mg m(-2) was administered on days 1 and 8 and cisplatin 60 mg m(-2) on day 1. Treatment was repeated every 3 weeks. Seven out of 54 patients (13.0%) had complete response, and partial response was observed in 33 (61.1%). The overall response rate was 74.1% (95% CI; 62.0-82.2%). Stable disease was observed in eight (14.8%) and no progressive disease was observed. After a median follow-up duration of 28.7 months, the median overall survival and progressive-free survival were 13.6 and 6.5 months, respectively. Major grade 3/4 toxicities were neutropenia (50.0%), anorexia (42.6%), diarrhoea (29.6%), fatigue (29.6%) and vomiting ( 13.0%). There was one treatment-related death owing to pneumonia. Three-week schedule of irinotecan/cisplatin showed effective antitumour activity and moderate toxicities in patients with previously untreated extensive-stage small-cell lung cancer.
키워드
- 제목
- Three-week schedule of irinotecan plus cisplatin in patients with previously untreated extensive-stage small-cell lung cancer
- 저자
- Hong, Y. S.; Lee, H. R.; Park, S.; Lee, S. C.; Hwang, I. G.; Park, B-B; Lee, J.; Ahn, J. S.; Ahn, M-J; Lim, H. Y.; Park, K.
- 발행일
- 2006-12-18
- 유형
- Article
- 권
- 95
- 호
- 12
- 페이지
- 1648 ~ 1652
- 언어
- ENG
- 출판사
- Nature Publishing Group
- 발행국가
- 영국
- 분량
- 5 페이지
- ISSN
- E 1532-1827
P 0007-0920